Trademark: 79158158
Word
CENTOXOME
Status Date
Friday, January 27, 2023
Registration Number
4995242
Registration Date
Tuesday, July 12, 2016
Filing Date
Tuesday, July 29, 2014
Published for Opposition
Tuesday, April 26, 2016
Cancellation Date
Friday, January 27, 2023
9 Scientific, surveying, weighing, measuring and checking apparatus and instruments, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, DNA fragmentation and capture devices, thermal cycler, and thermal blocks for incubations all to determine the structure, composition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genome, to determine structure, composition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratories, namely, scientific devices to determine DNA or RNA sequence, alterations, rearrangements, copy number variations, and deletions; devices to determine biochemical markers, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, and DNA fragmentation and capture devices all for scientific purposes; devices to prepare respective biological samples for acquiring measurements, namely, thermal cyclers, thermal blocks, magnetic beads, pipetting tips, microcentrifuge tubes, and 96-well microplates; pre-recorded compact discs, DVDs, downloadable audio and video digital recordings, and digital video discs, all featuring clinical phenotypic, genetic molecular and demographic information; computers; computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments
5 Pharmaceutical preparations for hereditary diseases, metabolic diseases, oncological diseases, complex multigenic diseases and veterinary preparations for hereditary diseases, metabolic diseases, oncological diseases, complex multigenic diseases; diagnostic preparations for medical or veterinary purposes, namely, for detecting hereditary diseases via DNA sequencing or detecting other genetic lesions especially on multiple genes or the whole genomic coding region or the whole genome, for detecting DNA lesions in somatic samples, for biochemical analysis of biological samples, for analysis of predisposition for genetically driven disorders, prediction and monitoring of treatment response in a clinical laboratory all for medical or veterinary purposes; chemical preparations for analyses in laboratories, for medical or veterinary purposes, namely, nucleic acid and chemical reagents; biological preparations for medical purposes, namely, for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases
35 Compilation and systematic ordering of data in a computer database; computerised file management especially for data coming from DNA analysis from multiple genes or the genomic coding region or the whole genome
44 Medical services, in particular medical analysis in connection with the treatment of individuals; providing information in the fields of medicine, veterinary medicine and pharmaceuticals; health centers, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; medical clinics; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases; medical laboratory services for the analysis of samples taken from patients, namely, medical testing of blood, tissue, saliva, urine, and hair follicle
42 Scientific and technological services, namely, genetic and biochemical analytical testing for scientific research purposes and new product research and design relating thereto; industrial analysis and research services in the field of genetics and in the field of pharmaceutical development; scientific research for medical purposes in the field of hereditary diseases, oncology, and complex genetics related diseases; design and development of computer hardware and computer software that support the processing and analysis of complex genomic data; medical research laboratory services
The mark consists of the stylized wording "CENTOXOME" in grey followed by a design of a rising sun in red.
The color(s) grey and red is/are claimed as a feature of the mark.
Oct 23, 2023
Total Invalidation Processed By The Ib
Sep 30, 2023
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 30, 2023
Invalidation Processed
Sep 27, 2023
Total Invalidation Of Reg Ext Protection Created
Jan 27, 2023
Cancelled Section 71
Jul 12, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 18, 2020
Change Of Name/Address Rec'd From Ib
Jul 26, 2018
Change Of Name/Address Rec'd From Ib
Jun 23, 2017
Notification Processed By Ib
Oct 12, 2016
Final Disposition Notice Created, To Be Sent To Ib
Jul 12, 2016
Registered-Principal Register
Jun 17, 2016
Notification Of Possible Opposition - Processed By Ib
Jun 1, 2016
Notification Of Possible Opposition Sent To Ib
Jun 1, 2016
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 26, 2016
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2016
Published For Opposition
Apr 6, 2016
Notification Of Possible Opposition Sent To Ib
Apr 6, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 6, 2016
Notification Of Notice Of Publication E-Mailed
Mar 18, 2016
Law Office Publication Review Completed
Mar 16, 2016
Assigned To Lie
Mar 15, 2016
Exparte Appeal Terminated
Mar 15, 2016
Approved For Pub - Principal Register
Feb 23, 2016
Examiner's Amendment Entered
Feb 23, 2016
Notification Of Examiners Amendment E-Mailed
Feb 23, 2016
Examiners Amendment E-Mailed
Feb 23, 2016
Examiners Amendment -Written
Feb 10, 2016
Teas/Email Correspondence Entered
Feb 10, 2016
Correspondence Received In Law Office
Feb 5, 2016
Assigned To Lie
Jan 27, 2016
Teas Request For Reconsideration Received
Jan 27, 2016
Ex Parte Appeal-Instituted
Jan 27, 2016
Jurisdiction Restored To Examining Attorney
Jan 27, 2016
Exparte Appeal Received At Ttab
Jul 28, 2015
Notification Of Final Refusal Emailed
Jul 28, 2015
Final Refusal E-Mailed
Jul 28, 2015
Final Refusal Written
Jul 9, 2015
Teas/Email Correspondence Entered
Jul 8, 2015
Correspondence Received In Law Office
Jul 8, 2015
Teas Response To Office Action Received
Jan 31, 2015
Refusal Processed By Ib
Jan 13, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Jan 13, 2015
Refusal Processed By Mpu
Jan 13, 2015
Application Filing Receipt Mailed
Jan 12, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Jan 11, 2015
Non-Final Action Written
Jan 7, 2015
Assigned To Examiner
Jan 7, 2015
New Application Office Supplied Data Entered
Jan 2, 2015
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
